Clinical trial
Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome
NCT02249169 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 19, 2014
- Completion date
- February 8, 2017
- Enrollment
- 84 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.